A promising response to osimertinib in a patient with erlotinib-resistant lung adenocarcinoma with an uncommon EGFR mutation

相似書籍

• Safety and efficacy of carboplatin plus nab-paclitaxel for treating advanced non-small-cell lung cancer with interstitial lung disease
  由: Niwa, Hideyuki, et al.
  出版: (2017)
• Successful osimertinib treatment in a patient who exhibited intramedullary spinal cord metastases of lung adenocarcinoma with an acquired EGFR T790M mutation
  由: Horiuchi, Kohei, et al.
  出版: (2019)
• MET amplification results in heterogeneous responses to osimertinib in EGFR‐mutant lung cancer treated with erlotinib
  由: Nishiyama, Akihiro, et al.
  出版: (2020)
• Predictive significance of thyroid transcription factor-1 expression in patients with non-squamous non-small cell lung cancer with wild-type epidermal growth factor receptor treated with erlotinib
  由: NAKAHARA, YOSHIRO, et al.
  出版: (2016)
• Uncommonly sited rare tumour causing nasal obstruction
  由: Apthorp, Christina, et al.
  出版: (2020)